{"transactions":[{"id":1792680,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-28","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":3.49,"value":349.0,"ownership":{"direct":true},"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1792679,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-25","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":3.5,"value":700.0,"ownership":{"direct":true},"balance_after":2650,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1792678,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-24","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":3.57,"value":714.0,"ownership":{"direct":true},"balance_after":2450,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1792677,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-23","kind":"purchase","planned":false,"acquired":true,"shares":200,"price":3.605,"value":721.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.58 to $3.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 4."}],"balance_after":2250,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1792676,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-22","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":3.51,"value":351.0,"ownership":{"direct":true},"balance_after":2050,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1792675,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-21","kind":"purchase","planned":false,"acquired":true,"shares":300,"price":3.6667,"value":1100.01,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.63 to $3.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 3."}],"balance_after":1950,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1792674,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-18","kind":"purchase","planned":false,"acquired":true,"shares":1200,"price":3.735,"value":4482.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.65 to $3.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2."}],"balance_after":1650,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1792673,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-08-31T01:52:31.000Z","date":"2023-08-17","kind":"purchase","planned":false,"acquired":true,"shares":450,"price":3.72,"value":1674.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.54 to $3.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1."}],"balance_after":450,"source":{"system":"sec-edgar","filing":"0001213900-23-072561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000121390023072561/ownership.xml","form_type":"4"}},{"id":1827510,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T00:33:39.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":480110,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options to purchase 480,110 shares of common stock of Legacy Carmell granted on September 23, 2021, which vest as follows: 25% vested on September 23, 2022 and the remaining 75% becomes vested in 36 equal monthly installments thereafter, subject to continued service through each vesting date."}],"balance_after":480110,"derivative":{"exercise_price":2.11,"expiration_date":"2031-09-23","underlying":"Common Stock","underlying_shares":480110},"source":{"system":"sec-edgar","filing":"0001062993-23-015052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000106299323015052/form4.xml","form_type":"4"}},{"id":1827509,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T00:33:39.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":37642,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to purchase 37,642 shares of common stock of Legacy Carmell (as defined below) granted on July 19, 2019, which vest as follows: 25% vested on July 19, 2020, July 19, 2021 and July 19, 2022.  The remaining 25% will vest and become exercisable on July 19, 2023."}],"balance_after":37642,"derivative":{"exercise_price":2.27,"expiration_date":"2029-07-19","underlying":"Common Stock","underlying_shares":37642},"source":{"system":"sec-edgar","filing":"0001062993-23-015052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000106299323015052/form4.xml","form_type":"4"}},{"id":1827508,"issuer":{"id":8659,"kind":"organization","name":"Longevity Health Holdings, Inc."},"owners":[{"id":110090,"kind":"person","name":"Hubbell Randolph W","position":1,"cik":"0001984207","reported_name":"Hubbell Randolph W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T00:33:39.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":217175,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 14, 2023, Alpha Healthcare Acquisition Corp. III (\"ALPA\") consummated a business combination (the \"Business Combination\") by and among ALPA, Candy Merger Sub, Inc., a Delaware Corporation (\"Merger Sub\") and Carmell Regen Med Corporation, a Delaware corporation (\"Legacy Carmell\"), ALPA changed its name to \"Carmell Therapeutics Corporation\" and Merger Sub merged with and into Legacy Carmell.  As part of the Business Combination, each Legacy Carmell stock option was exchanged for a stock option to acquire 0.06154 shares of common stock of Carmell Therapeutics Corporation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options are fully vested and exercisable."}],"balance_after":217175,"derivative":{"exercise_price":1.79,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":217175},"source":{"system":"sec-edgar","filing":"0001062993-23-015052","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842939/000106299323015052/form4.xml","form_type":"4"}}]}